Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.

Cha JO, Park YK, Lee YS, Chung GT.

Diagn Microbiol Infect Dis. 2011 May;70(1):112-8. doi: 10.1016/j.diagmicrobio.2010.11.018. Epub 2011 Mar 12.

PMID:
21398072
2.

Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.

Smith K, Perez A, Ramage G, Gemmell CG, Lang S.

Int J Antimicrob Agents. 2009 Apr;33(4):374-8. doi: 10.1016/j.ijantimicag.2008.08.029. Epub 2008 Dec 19.

PMID:
19101124
3.

Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.

Cafiso V, Bertuccio T, Spina D, Purrello S, Stefani S.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):466-9. doi: 10.1111/j.1574-695X.2010.00701.x. Epub 2010 May 19.

4.

In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.

Kao TM, Wang JT, Weng CM, Chen YC, Chang SC.

J Microbiol Immunol Infect. 2011 Oct;44(5):346-51. doi: 10.1016/j.jmii.2011.01.037. Epub 2011 Jan 20.

5.

In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).

Tang HJ, Chen CC, Ko WC, Yu WL, Chiang SR, Chuang YC.

Int J Antimicrob Agents. 2011 Jul;38(1):46-51. doi: 10.1016/j.ijantimicag.2011.02.013. Epub 2011 May 6.

PMID:
21549575
6.

Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.

Rose WE, Poppens PT.

J Antimicrob Chemother. 2009 Mar;63(3):485-8. doi: 10.1093/jac/dkn513. Epub 2008 Dec 24.

7.

A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.

Bauer J, Siala W, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother. 2013 Jun;57(6):2726-37. doi: 10.1128/AAC.00181-13. Epub 2013 Apr 9.

9.

Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.

Nam HM, Lee AL, Jung SC, Kim MN, Jang GC, Wee SH, Lim SK.

Foodborne Pathog Dis. 2011 Feb;8(2):231-8. doi: 10.1089/fpd.2010.0661. Epub 2010 Oct 30.

PMID:
21034263
10.

Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.

Atshan SS, Nor Shamsudin M, Lung LT, Sekawi Z, Pei Pei C, Karunanidhi A, Jeevajothi Nathan J, Mateg Ali A, Ghaznavi-Rad E, Abduljaleel SA, Awang Hamat R.

Biomed Res Int. 2013;2013:515712. doi: 10.1155/2013/515712. Epub 2013 Dec 25.

11.

[Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].

Kotulová D, Slobodníková L.

Epidemiol Mikrobiol Imunol. 2010 Apr;59(2):80-7. Slovak.

PMID:
20586169
12.
13.

In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.

McConeghy KW, LaPlante KL.

Diagn Microbiol Infect Dis. 2010 Sep;68(1):1-6. doi: 10.1016/j.diagmicrobio.2010.04.011.

PMID:
20727462
14.

In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.

Tang HJ, Chen CC, Cheng KC, Toh HS, Su BA, Chiang SR, Ko WC, Chuang YC.

J Antimicrob Chemother. 2012 Apr;67(4):944-50. doi: 10.1093/jac/dkr535. Epub 2012 Jan 18.

15.

Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.

Torrico M, Giménez MJ, González N, Alou L, Sevillano D, Cafini F, Prieto J, Cleeland R, Aguilar L.

Int J Antimicrob Agents. 2010 Feb;35(2):131-7. doi: 10.1016/j.ijantimicag.2009.09.021. Epub 2009 Dec 16.

PMID:
20006469
16.

[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5. Spanish.

PMID:
19406529
17.

Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs.

Reiter KC, Villa B, Paim TG, de Oliveira CF, d'Azevedo PA.

J Med Microbiol. 2013 Mar;62(Pt 3):394-9. doi: 10.1099/jmm.0.048678-0. Epub 2012 Nov 15.

PMID:
23161766
19.

Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.

Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP.

Antimicrob Agents Chemother. 2009 Dec;53(12):5141-4. doi: 10.1128/AAC.00307-09. Epub 2009 Oct 5.

20.

Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.

Parra-Ruiz J, Bravo-Molina A, Peña-Monje A, Hernández-Quero J.

J Antimicrob Chemother. 2012 Nov;67(11):2682-5. doi: 10.1093/jac/dks272. Epub 2012 Jul 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk